####################
# Output from PRIME (v2.0)
# Alleles: A3101
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_A3101	Score_A3101	%RankBinding_A3101
GGWGGLFHH	0.775	0.040606	2.446	A3101	0.775	0.040606	2.446
RASGTPGLRAR	0.776	0.040553	0.120	A3101	0.776	0.040553	0.120
QAIYKFQSR	0.078	0.146246	0.107	A3101	0.078	0.146246	0.107
TMNEYIKQR	0.029	0.199386	0.028	A3101	0.029	0.199386	0.028
